Alnylam PharmaceuticalsvsThermo Fisher Scientific

ALNY and TMO stock compared: price, dividend, valuation and results, from SEC filings.

ALNY

Alnylam Pharmaceuticals, Inc.

$149.40

Value $19.8B

-4.54%
ALNY's page

TMO

Thermo Fisher Scientific Inc

$692.83

Value $257B

+0.87%
TMO's page

Alnylam Pharmaceuticals (ALNY) has a market value of $19.8B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, ALNY moved -67.6% and TMO +22.6%. Dividend yield: ALNY none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ALNY$19.8B

    TMO$257B

    TMO is 13 times ALNY

  • Revenue, 12 months

    ALNY$5.0B

    TMO$47.4B

    TMO is 9.4 times ALNY

  • Net income, 12 months

    ALNY$2.6B

    TMO$7.1B

    TMO is 2.7 times ALNY

  • Operating margin

    ALNY19.5%

    TMO17.9%

    1.6 points apart

  • ROIC

    ALNY31.8%

    TMO8.2%

    23.6 points apart

  • P/E

    ALNY–

    TMO36.4

  • Dividend yield

    ALNY0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    ALNY-13.5%

    TMO+10.3%

    23.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ALNY-13.5%

TMO+10.3%

10020020222023202420252026
Returns by period
PeriodALNYWith dividendsTMOWith dividends
1 year since November 17, 2025-67.6%Price -67.6%+22.6%Price +22.2%
3 years since November 17, 2023-8.8%-3.0% a yearPrice -8.8%+50.0%+14.5% a yearPrice +48.5%
5 years since November 17, 2021-13.5%-2.9% a yearPrice -13.5%+10.3%+2.0% a yearPrice +8.7%
10 years since November 18, 2016+224.9%+12.5% a yearPrice +224.9%+388.8%+17.2% a yearPrice +375.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ALNYAlnylam PharmaceuticalsTMOThermo Fisher Scientific

Valuation

ALNYTMO
Valuation
Price$149.40$692.83
Market value$19.8B$257B
Enterprise value (EV)–$293B
P/E–36.4
P/E, 5-year median–32.7
P/B5.54.7
EV/EBIT–34.6
Free cash flow yield4.1%2.9%

Results and growth

ALNYTMO
Results and growth
Revenue, 12 months$5.0B$47.4B
Net income, 12 months$2.6B$7.1B
Free cash flow, 12 months$806M$7.6B
Earnings per share, 12 months$19.98$18.96
Revenue growth, year on year65.2%3.9%
Revenue growth a year, past+49.8%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

ALNYTMO
Margins and returns on capital
Gross margin77.4%–
Operating margin19.5%17.9%
Net margin52.8%14.9%
ROIC31.8%8.2%
ROE178.9%13.4%

Balance sheet

ALNYTMO
Balance sheet
Cash$3.6B$6.1B
Total debt–$41.4B
Net debt / EBITDA–3.7
Interest cover3.3×5.5×

Dividends and buybacks

ALNYTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ALNY or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Alnylam Pharmaceuticals or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 13.0 times Alnylam Pharmaceuticals ($19.8B), at today's prices.

How did ALNY and TMO stock do over the last 10 years?

Since November 18, 2016, ALNY's price moved +224.9% and TMO's +375.2%. With dividends: ALNY +224.9% (+12.5% a year), TMO +388.8% (+17.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ALNY or TMO?

The dividend yield at today's price is none for Alnylam Pharmaceuticals and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Alnylam Pharmaceuticals or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 52.8% for Alnylam Pharmaceuticals and 14.9% for Thermo Fisher Scientific, and the operating margin 19.5% and 17.9%. Revenue was $5.0B and $47.4B.

Which is the better investment, Alnylam Pharmaceuticals or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.